NEWBORN SCREENING OUALITY ASSURANCE PROGRAM CYSTIC FIBROSIS VARIANT DETECTION SURVEY
GUARTER 4 - NOYEMBER 2018
LAB 1268
DATA YERIFICATION
i Specimen ] Nuntber |
Alicie 1 1, .j-7 'J .1 |
. jjble 2.1 |
Clinical Assessment |
418C1 |
F508del (c.1521_1523delCTT) |
F508del (c.1521J523deiCTT) |
j 2 |
416C2 ł |
No variants deteeted |
No variants deteeted |
■1! |
1 418C3 |
F508del (c.l521_1523delCTT) |
No variants deteeted |
2 |
418C4 |
3849+1Okb C>T (c.3717+12191C>T) |
G542X (c.1624G>T) |
2 i' |
418C5 |
2183AA>G (c.2051_2052delAAinsG) |
No variants deteeted |
2 |
NSOAP ReYiewer^s Comments
100% satisfactory based on the reported variant panel.
Please notę that specimen 418C3 contains a CF-causing variantthat is not deteeted using your reported variant panel
Resuits have been
mwycznej Title
■ « _
- ~r
IM
talm&ofA
lahorataryjr.B,
Datę
if you have any questions about your resuits, please contact Suzanne K. Cordovado by email at SCordovado@cdc.0ov by telephone at 770-488^4048 or the Newbom Screening Quality Assurai Program at NSQAPDMT@cdc.gov,